BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sardi A, Sipok A, Baratti D, Deraco M, Sugarbaker P, Salti G, Yonemura Y, Sammartino P, Glehen O, Bakrin N, Díaz-Montes TP, Gushchin V. Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2017;43:2170-7. [PMID: 28967566 DOI: 10.1016/j.ejso.2017.08.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 . Secondary Malignant Neoplasms. Tumors of the Serosal Membranes 2022. [DOI: 10.55418/9781933477190-7] [Reference Citation Analysis]
2 Baghban R, Afarid M, Soleymani J, Rahimi M. Were magnetic materials useful in cancer therapy? Biomed Pharmacother 2021;144:112321. [PMID: 34656061 DOI: 10.1016/j.biopha.2021.112321] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
3 Wong LCK, Li Z, Fan Q, Tan JW, Tan QX, Wong JSM, Ong CJ, Chia CS. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal sarcomatosis-A systematic review and meta-analysis. Eur J Surg Oncol 2021:S0748-7983(21)00761-7. [PMID: 34716035 DOI: 10.1016/j.ejso.2021.10.013] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Lee JS, Lee D, Lee J, Han MH, Hong DG, Lee HJ. Primary ovarian high-grade endometrial stromal sarcoma: a case report. J Med Case Rep 2021;15:387. [PMID: 34340706 DOI: 10.1186/s13256-021-02986-0] [Reference Citation Analysis]
5 Yasukawa M, Dainty LA, Sugarbaker PH. Long-term outcomes after cytoreductive surgery and HIPEC for morcellated uterine leiomyosarcoma; A case series. Gynecol Oncol Rep 2021;36:100741. [PMID: 33748383 DOI: 10.1016/j.gore.2021.100741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Matsuzaki S, Matsuzaki S, Chang EJ, Yasukawa M, Roman LD, Matsuo K. Surgical and oncologic outcomes of hyperthermic intraperitoneal chemotherapy for uterine leiomyosarcoma: A systematic review of literature. Gynecol Oncol 2021;161:70-7. [PMID: 33419612 DOI: 10.1016/j.ygyno.2020.12.032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
7 Bacalbasa N, Balescu I, Iliescu L, Diaconu C, Dima S, Vilcu M, Brezean I. Urinary Tract Resections as Part of Debulking Surgery for Locally Advanced Endometrial Stromal Sarcomas. In Vivo 2020;34:793-7. [PMID: 32111786 DOI: 10.21873/invivo.11840] [Reference Citation Analysis]
8 Ferrandina G, Aristei C, Biondetti PR, Cananzi FCM, Casali P, Ciccarone F, Colombo N, Comandone A, Corvo' R, De Iaco P, Dei Tos AP, Donato V, Fiore M, Franchi, Gadducci A, Gronchi A, Guerriero S, Infante A, Odicino F, Pirronti T, Quagliuolo V, Sanfilippo R, Testa AC, Zannoni GF, Scambia G, Lorusso D. Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia). Eur J Cancer 2020;139:149-68. [PMID: 32992154 DOI: 10.1016/j.ejca.2020.08.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
9 Tsuyoshi H, Inoue D, Kurokawa T, Yoshida Y. Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer. J Obstet Gynaecol Res 2020;46:1661-71. [DOI: 10.1111/jog.14391] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
10 Findlay BL, Gargollo PC, Granberg CF. Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Pediatric Sarcoma for Maximal Oncologic Control. Urology 2020;141:139-42. [PMID: 32333983 DOI: 10.1016/j.urology.2020.04.032] [Reference Citation Analysis]
11 White ME, Yang C, Hokamp JA, Wellman ML. Fibrosarcoma with sarcomatosis and metastasis in a FeLV-negative cat. Vet Clin Pathol 2020;49:143-6. [PMID: 32232857 DOI: 10.1111/vcp.12842] [Reference Citation Analysis]
12 Bizzarri N, Ghirardi V, Di Fiore GLM, De Iaco P, Gadducci A, Casarin J, Perrone AM, Pasciuto T, Scambia G, Fagotti A. Secondary cytoreductive surgery in recurrent uterine leiomyosarcoma: a multi-institutional study. Int J Gynecol Cancer 2019;29:1134-40. [PMID: 31420411 DOI: 10.1136/ijgc-2019-000355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nizri E, Fiore M, Barretta F, Colombo C, Radaelli S, Callegaro D, Sanfilippo R, Sangalli C, Collini P, Stacchiotti S, Casali PG, Miceli R, Gronchi A. Intraperitoneal Invasion of Retroperitoneal Sarcomas: A Risk Factor for Dismal Prognosis. Ann Surg Oncol 2019;26:3535-41. [DOI: 10.1245/s10434-019-07615-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
14 Díaz-montes TP, El-sharkawy F, Lynam S, Harper A, Sittig M, Macdonald R, Gushchin V, Sardi A. Efficacy of Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Treatment of Recurrent Uterine Sarcoma: . International Journal of Gynecological Cancer 2018;28:1130-7. [DOI: 10.1097/igc.0000000000001289] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]